Jpmorgan Chase & CO Natera, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NTRA
# of Institutions
439Shares Held
117MCall Options Held
254KPut Options Held
263K-
Vanguard Group Inc Valley Forge, PA11MShares$1.2 Billion0.02% of portfolio
-
Fred Alger Management, LLC New York, NY6.55MShares$709 Million3.03% of portfolio
-
Black Rock Inc. New York, NY6.49MShares$702 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.93MShares$425 Million1.68% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.44MShares$373 Million0.09% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $10.5B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...